Financial News · Live Terminal

Page 1013 of 1191

Rongsheng Petrochemical Q1 Profit Jumps 378%; Shares Up 3%

Rongsheng Petrochemical (SHE:002493) posted first-quarter attributable net profit of 2.82 billion yuan, up 378% from 588.4 million yuan the previous year.Earnings per share rose to 0.29 yuan from 0.06 yuan, according to a Tuesday filing with the Shenzhen bourse.Revenue declined 19% year over year to 60.6 billion yuan from 75.0 billion yuan.Shares of the petrochemical company rose 3% in recent trade.

SHE:002493

Asia107d ago

Guangdong HEC Technology's Q1 Profit Plunges 57%, Revenue Up 27%

Guangdong HEC Technology (SHA:600673) posted first-quarter attributable net profit of 119.3 million yuan, down 57% from 278 million yuan the previous year.Earnings per share fell to 0.04 yuan from 0.095 yuan, according to a Tuesday filing with the Shanghai bourse.The electronic components manufacturer's revenue rose 27% year over year to 4.25 billion yuan from 3.35 billion yuan.Shares of the company climbed almost 3% in recent trade.

SHA:600673

Asia107d ago

Stimulation Equipment Arrives at Elixir Energy's Queensland Well Site, Shares Up 7%

Elixir Energy (ASX:EXR) said stimulation equipment arrived and rigging up began at the Diona-1 well site in the Surat-Bowen basin in Queensland, according to a Tuesday Australian bourse filing.The equipment will be used for the three-zone fracture stimulation operations of the net gas-condensate pay measured at Diona-1.Flowback, production, and pressure-monitoring tests will begin at the well after fracture stimulation, completion, and rigging up of well testing equipment.Its shares rose 7% in recent trading on Tuesday.

ASX:EXR

Asia107d ago

Guofu Hydrogen Energy Invests $3.6 Million in U Power

Jiangsu Guofu Hydrogen Energy Equipment (HKG:2582) agreed to invest $3.6 million in Nasdaq-listed U Power for an 8.70% stake in the business, according to a Hong Kong bourse filing Monday.Shares of the hydrogen energy equipment provider fell over 1% in morning trade Tuesday.Guofu Hydrogen said the subscription is a long-term investment which "may bring positive returns."

HKG:2582

Asia107d ago

Tianyu Semiconductor's Loss Narrows in 2025

Guangdong Tianyu Semiconductor (HKG:2658) posted a loss attributable to equity shareholders of 55.6 million yuan for 2025, narrowing from a loss of 492.5 million yuan a year earlier, according to a Monday Hong Kong bourse filing.Shares of the firm were down over 2% in Tuesday morning trade.Loss per share came in at 0.15 yuan, compared with 1.36 yuan in 2024.Revenue rose 37% to 709.2 million yuan from 519.6 million yuan a year earlier.

HKG:2658

Asia107d ago

Mapletree Pan Asia Commercial Trust's DPU Declines 2.6% in Fiscal Q4

Mapletree Pan Asia Commercial Trust's (SGX:N2IU) distribution per unit or DPU fell by 2.6% in the fiscal fourth quarter ended March 31 to SG$0.019 from SG$0.0195 a year earlier, according to a Tuesday filing with the Singapore Exchange.Amount available for distribution to unitholders was down 3.3% to SG$100.2 million from SG$103.6 million.Net property income declined by 5.9% to SG$159.6 million from SG$169.5 million in the year-ago period.Gross revenue edged down 5.5% year over year to SG$210.7 million from SG$222.9 million, despite an improved portfolio committed occupancy of 89.4% compared to the previous quarter.

SGX:N2IU

Asia107d ago

First Graphene Agrees to Acquire Graphene Technology Company Assets

First Graphene (ASX:FGR) agreed to acquire all manufacturing, intellectual property, and development assets of Ionic Industries and its Imagine Intelligent Materials subsidiary for a total consideration of AU$250,000 in cash and shares, according to a Tuesday filing with the Australian bourse.The acquisition is expected to settle within 90 days, the filing said.First Graphene's shares rose nearly 2% in midday trade Tuesday.

ASX:FGR

Asia107d ago

Sichuan Biokin Pharma Posts 128% Profit Drop in 2025 as Revenue Halves; Shares Down 3%

Sichuan Biokin Pharmaceutical (SHA:688506) reported a 128% decrease in net profit in 2025 to 1.05 billion yuan from 3.71 billion yuan a year earlier.Earnings per share plunged to 2.61 yuan from 9.25 yuan, the pharmaceutical company said in a Shanghai bourse filing on Tuesday.Revenue slumped 57% to 2.52 billion yuan from 5.82 billion yuan.Biokin attributed the lackluster performance to a high comparison base as the revenue generated in 2024 benefited from the intellectual property cooperation agreement it reached with BMS on a product called Iza-bren.Shares of the company fell 3% in recent trade.

SHA:688506

Asia107d ago

Piotech Returns to Profit in Q1; Shares Up 3%

Piotech (SHA:688072) booked a net profit of 570.6 million yuan in the first quarter of 2026, reversing a net loss of 147 million yuan a year earlier, according to a Shanghai bourse filing on Tuesday.The Chinese semiconductor device manufacturer posted earnings per share of 2.00 yuan, versus a loss per share of 0.52 yuan in Q1 2025.The recovery came as revenue jumped 57% to 1.11 billion yuan from 708.7 million yuan.Shares of the company rose 3% in morning trade on Tuesday.

SHA:688072

Asia107d ago

Tinci Materials Technology Q1 Profit Soars 1,062%, Revenue Jumps 91%

Guangzhou Tinci Materials Technology (SHE:002709) posted first-quarter attributable net profit of 1.65 billion yuan, soaring 1,062% from 149.6 million yuan the previous year.Earnings per share jumped to 0.81 yuan from 0.08 yuan, according to a Tuesday filing with the Shenzhen bourse.Revenue went up 91% year over year to 6.67 billion yuan from 3.49 billion yuan.Shares of the new energy material manufacturer declined 1% in recent trade.

SHE:002709

Asia107d ago

FortifAI Secures AU$15 Million in Strategic Placement to Accelerate Growth; Shares Hit Three-Year High

FortifAI (ASX:FTI) has secured firm commitments to raise AU$15 million through a placement to institutional and sophisticated investors, issuing around 21 million new fully paid ordinary shares at AU$0.715 each, according to a Tuesday filing with the Australian bourse.The shares will settle on May 6 and are expected to be allotted around May 7, per the filing.The funds will be used to strategically support the company's growth objectives by accelerating technology, marketing, and business development for Nol8 Technology, enhancing business development programs for existing assets, strengthening commercial initiatives, and providing general working capital, the filing added.The company's shares jumped 27% in recent Tuesday trade, earlier hitting their highest level since April 2023.

ASX:FTI

Asia107d ago

Haitian Flavouring and Food's Q1 Profit Rises 11%, Revenue Up 9%

Foshan Haitian Flavouring and Food's (SHA:603288, HKG:3288) net profit attributable to shareholders in the first quarter rose 11% to 2.44 billion yuan from 2.20 billion yuan a year ago, according to a Hong Kong bourse filing on Monday.The condiment maker's Shanghai shares slipped 1% during the morning trade.Earnings per share increased 5% year on year to 0.42 yuan from 0.40 yuan.Operating revenue climbed 8.6% to 9.03 billion yuan from 8.32 billion yuan in the previous year.

HKG:3288SHA:603288

Asia107d ago

Market Chatter: Idemitsu to Route 4 Million Barrels to Vietnam Outside Hormuz

Idemitsu Kosan (TYO:5019) will supply Vietnam with about 4 million barrels of Middle Eastern crude via routes that bypass the Strait of Hormuz, Nikkei reported Tuesday.The cargo will be refined in Vietnam into fuels and petrochemical feedstocks, supporting supply chains that feed plastic components into Japan's auto, appliance and consumer goods sectors, according to the report.The volume equals roughly 10 days of Vietnam's crude demand and is expected to help maintain operations for Japanese manufacturers in the country. Hanoi has faced challenges securing crude and sought support from Tokyo earlier this year, the report said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

TYO:5019

Asia107d ago

Dimerix Says Phase 3 Clinical Trial Data Review Shows Over 90% Statistical Power to Detect Proteinuria Treatment Effect; Shares Reach Two-Year Low

Dimerix (ASX:DXB) said an external statistical blinded review of the data from the ACTION3 phase 3 clinical trial, evaluating its DMX-200 drug candidate in patients with focal segmental glomerulosclerosis, confirmed that the study had an over 90% statistical power to detect the treatment effect for the proteinuria primary endpoint, according to a Tuesday Australian bourse filing.The US Food and Drug Administration (FDA) previously confirmed that the proposed primary endpoint of percent reduction in proteinuria compared to placebo could support traditional approval of its DMX-200 drug candidate via the 505(b)(1) pathway, should the findings of the study be positive.Its shares fell 35% in recent trading on Tuesday, reaching a two-year low.

ASX:DXB

Asia107d ago

Orthocell Says Post-Market Follow-Up Study Shows Overall Treatment Success Rate of Nearly 90% for Nerve Repair Product; Shares Jump 4%

Orthocell (ASX:OCC) said results from an ongoing multi-center post-market clinical follow-up study for its nerve repair product, Remplir, showed an overall treatment success rate of nearly 90%, based on performance data from 66 patients, according to a Tuesday Australian bourse filing.The company said over 90% of motor nerve repairs resulted in functional muscle recovery, while more than 89% of nerve decompression procedures resulted in complete relief or significant improvement of symptoms.The patients were aged 14 to 82 years, and the majority of the procedures were performed in the upper limb. No post-treatment complications or adverse effects were reported.Orthocell's shares jump nearly 4% in recent trading on Tuesday.

ASX:OCC

Asia107d ago

Tianqi Lithium's Q1 Profit Surges 18-Fold as Revenue Nearly Doubles

Tianqi Lithium (HKG:9696, SHE:002466) posted a 1,699% year-over-year jump in attributable net profit in the first quarter to 1.88 billion yuan from 104.3 million yuan, according to filings with the Hong Kong and Shenzhen bourses late Monday.The pace of growth was in line with the company's guidance of a 1,530% to 1,818% expansion issued last week.Earnings per share rose to 1.10 yuan from 0.06 yuan.Revenue climbed 98% to 5.13 billion yuan from 2.58 billion yuan in Q1 2025.Shares of the lithium company fell marginally in Hong Kong, and were down more than 1% in Shenzhen Tuesday morning.

HKG:9696SHE:002466

Asia107d ago

Inovance Technology Q1 Profit Down 23%; Shares Fall 7%

Shenzhen Inovance Technology (SHE:300124) posted first-quarter attributable net profit of 1.01 billion yuan, down 23% from 1.32 billion yuan the previous year.Earnings per share declined to 0.37 yuan from 0.49 yuan, according to a Tuesday filing with the Shenzhen bourse.Revenue climbed 13% year over year to 10.1 billion yuan from 8.98 billion yuan.Shares of the robot maker fell 7% in recent trade.

SHE:300124

Asia107d ago

Market Chatter: South Korea Becomes Eighth-Largest Stock Market in the World

South Korea became the eighth-largest stock market in the world after the total market capitalization of South Korean-listed companies surged over 45% in 2026 to hit $4.04 trillion, Bloomberg News reported Tuesday.South Korea surpassed the UK to take the spot, with the total market capitalization of UK-listed firms gaining about 3% to reach $3.99 trillion, the report said.The surge in Korean stock prices is a result of gains made by firms related to AI, in particular, Samsung Electronics (KRX:005930) and SK Hynix (KRX:000660). These two firms make up for more than 40% of the total market capitalization of the country's primary index, the Korea Composite Stock Price Index, or Kospi, according to the report.The surge in Korean stock prices is similar to gains in Taiwan, which overtook the UK in April to become the world's seventh-largest equity market. Taiwan's rally was driven largely by Taiwan Semiconductor Manufacturing (TPE:2330), which makes up about 45% of its benchmark index. Taiwan's total market value has hit $4.48 trillion, the report said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

^KOSDAQKOSPIKRX:000660KRX:005930TPE:2330

Asia107d ago

Cleo Diagnostics Starts Manufacturing, Development Program for Ovarian Cancer Test Kit Production; Shares Up 8%

Cleo Diagnostics (ASX:COV) started a staged manufacturing and development program with life sciences firm Bio-Techne to support production of its ovarian cancer test kits, according to a Tuesday filing with the Australian bourse.The program will generate the test kits required for analytical validation and the evaluation of the clinical samples collected as part of the company's US study, the filing said.Data from analytical validation and clinical sample testing will form the core evidence package for the company's US Food and Drug Administration 510(k) submission, per the filing.Cleo Diagnostics shares rose 8% in midday trade on Tuesday.

ASX:COV

Asia107d ago

Guangdong Songfa Ceramics' Q1 Profit Quadruples as Revenue Doubles; Shares Jump 4%

Guangdong Songfa Ceramics (SHA:603268) posted a 330% year-over-year jump in net profit in the first quarter of 2026 to 1.09 billion yuan from 254.1 million yuan.Earnings per share, however, slipped 45% to 1.13 yuan from 2.05 yuan, the ceramics maker said in a Shanghai Stock Exchange filing on Tuesday.Revenue surged 199% to 8.89 billion yuan from 2.97 billion yuan a year earlier.Songfa's shares rose nearly 4% in recent trade.

SHA:603268

Showing 20241-20260 of 23809